Search
for
Sort by
Research 691–720 of 1000+
- Supplemental figure 2 from Effect of Combined Treatment with Ursolic Acid and Resveratrol on Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of <i>Retinoblastoma</i> and <i>Trp53</i> Tumor Suppressors
- Data from Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of <i>Retinoblastoma</i> and <i>Trp53</i> Tumor Suppressors
- 546 Epidermal growth factor receptor as a key regulator of the immune privilege
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Drug Repurposing Patent Applications April–June 2021
- Avaliação do efeito do ácido piperonílico na cicatrização de feridas em camundongos
- 078 The transmembrane protein LRIG1 regulates receptor tyrosine kinases in skin development and homeostasis
- 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
- Cross-section trichometry, a clinical tool for assessing the progression and treatment response of alopecia
- Becker nevus of the face with asymmetrical growth of beard hair
- Association between epidermal growth factor and epidermal growth factor receptor gene polymorphisms and susceptibility to alopecia areata in Korean population
- Abstract 2559: Targeting mTORC1 may provide selectivity for inhibiting proliferation of hair follicle stem/progenitor cells during tumor promotion
- News in brief
- Epidermal Growth Factor Receptor Regulates Skin Nerve Outgrowth and Branching
- Epimorphin and Epithelial Morphogenesis
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- PA11 A rare case of a severe papulopustular dermatosis secondary to a germline <i>EGFR</i> mutation
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- PRIDE syndrome with lumbosacral hypertrichosis
- Cetuximab Induced Hidrocystomas: A Case Report
- A Story About Hair
- Salt-losing tubulopathy and chronic dermatitis
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy